Discontinued — last reported Q4 '25
Thermo Fisher Scientific Change in Tax Valuation Allowance increased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 100.0%, from -$28.00M to $0.00. This is a positive signal — lower values indicate better performance for this metric.
A decrease in the allowance is generally positive, suggesting improved confidence in realizing tax benefits; an increase suggests potential impairment of tax assets.
This metric tracks changes in the valuation allowance established against deferred tax assets, reflecting management's a...
Standard disclosure for companies with significant deferred tax assets or historical losses.
is_tmo_tax_valuation_allowance_change| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $30.00M | -$11.00M | -$87.00M | -$88.00M | $415.00M | $67.00M | -$1.00M | -$183.00M | $47.00M | -$183.00M | -$25.00M | -$28.00M | $0.00 |
| QoQ Change | — | -136.7% | -690.9% | -1.1% | +571.6% | -83.9% | -101.5% | <-999% | +125.7% | -489.4% | +86.3% | -12.0% | +100.0% |
| YoY Change | — | — | — | -393.3% | >999% | +177.0% | +98.9% | -144.1% | -29.9% | <-999% | +86.3% | -159.6% | +100.0% |